Is SOPHiA GENETICS SA (SOPH) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 10.2% / 30% | 27.2% / 30% | 2.9% / 30% | 5.16% / 5% | ✗ NOT HALAL |
| DJIM | 10.2% / 33% | 27.2% / 33% | 2.9% / 33% | 5.16% / 5% | ✗ NOT HALAL |
| MSCI | 19.3% / 33% | 51.7% / 33% | 5.6% / 33% | 5.16% / 5% | ✗ NOT HALAL |
| S&P | 10.2% / 33% | 27.2% / 33% | 2.9% / 33% | 5.16% / 5% | ✗ NOT HALAL |
| FTSE | 19.3% / 33% | 51.7% / 33% | 5.6% / 50% | 5.16% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 67.4% | |
| Operating Margin | -85.4% | |
| Net Margin | -102.2% | |
| Return on Equity (ROE) | -110.0% | |
| Return on Assets (ROA) | -27.9% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$36M |
| Free Cash Flow | -$45M |
| Total Debt | $63M |
| Debt-to-Equity | 133.7 |
| Current Ratio | 2.0 |
| Total Assets | $163M |
Price & Trading
| Last Close | $4.73 |
| 50-Day MA | $4.85 |
| 200-Day MA | $4.18 |
| Avg Volume | 195K |
| Beta | 1.1 |
|
52-Week Range
$2.58
| |
About SOPHiA GENETICS SA (SOPH)
SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. The company was incorporated in 2011 and is based in Rolle, Switzerland.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is SOPHiA GENETICS SA (SOPH) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), SOPHiA GENETICS SA is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is SOPHiA GENETICS SA's debt ratio?
SOPHiA GENETICS SA's debt ratio is 10.2% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 19.3%.
What are SOPHiA GENETICS SA's key financial metrics?
SOPHiA GENETICS SA has a market capitalization of $337M, and revenue of $77M. The company maintains a gross margin of 67.4% and a net margin of -102.2%. Return on equity stands at -110.0%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.